To the Editor:
Thromboembolic events have been described among individuals infected with SARS-CoV-2, particularly in critically ill patients, and therefore thromboprophylaxis is recommended in these patients. A high level of suspicion concerning bleeding complications in patients under anticoagulation is required in order to promptly recognize the hemorrhage and immediately suspend the anticoagulation. We describe the case of a 72-year-old male with severe COVID-19 who received thromboembolism prophylaxis with enoxaparin.

Click here for the full paper.